Biological and Behavioral Outcomes of Community Nature Walks

Sponsor
Charlotte Tate (Other)
Overall Status
Recruiting
CT.gov ID
NCT06056375
Collaborator
University of California, San Francisco (Other)
200
1
1
43
4.7

Study Details

Study Description

Brief Summary

The investigators will test the efficacy of our proposed intervention to reduce embodied stress in four racial/ethnic groups (Black, Latinx, Pilipinx, and Pacific Islander) as a preventative intervention for health disparities found in these communities. The intervention is comprised of two phases. The first consists of community nature walks in a pristine redwood forest for six months. This is followed by chosen nature activities with family and/or friends for three months. The investigators will test the ability of these activities in nature to reduce chronic stress that underpins many health disparities using validated biological, behavioral, and sociocultural measures. The use of these measures is in alignment with the National Institute of Minority Health and Health Disparities (NIMHD) Research Framework, and will increase understanding of individual, interpersonal, community, and social level factors that lead to, and that can eliminate health disparities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Reclaiming Nature Intervention
Phase 1

Detailed Description

The investigators will test the efficacy of our proposed intervention to reduce embodied stress in four racial/ethnic groups (Black, Latinx, Pilipinx, and Pacific Islander) as a preventative intervention for health disparities found in these communities. The intervention is comprised of two phases. The first consists of community nature walks in a pristine redwood forest for six months. This is followed by chosen nature activities with family and/or friends for three months. The investigators will test the ability of these activities in nature to reduce chronic stress that underpins many health disparities using validated biological, behavioral, and sociocultural measures. The use of these measures is in alignment with the National Institute of Minority Health and Health Disparities (NIMHD) Research Framework, and will increase understanding of individual, interpersonal, community, and social level factors that lead to, and that can eliminate health disparities.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Non-Randomized
Intervention Model:
Sequential Assignment
Intervention Model Description:
Waitlist control designWaitlist control design
Masking:
None (Open Label)
Masking Description:
Since the study is a waitlisted control, all participants are aware of which condition they are in at any time.
Primary Purpose:
Prevention
Official Title:
Examining Anti-Racist Healing in Nature to Protect Telomeres of Transitional Age BIPOC for Health Equity
Actual Study Start Date :
Feb 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2024
Anticipated Study Completion Date :
Sep 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Other: Waitlist Control

Waitlist control; all participants receive the treatment but are in a control condition prior to the treatment

Behavioral: Reclaiming Nature Intervention
The purpose of the community intervention is to prevent health disparities in Black, Latinx, Pilipinx, and Pacific Islander communities of San Francisco, California.

Outcome Measures

Primary Outcome Measures

  1. Relative Telomere Length [Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention]

    Relative Telomere Length in the name of the outcome measure.

Secondary Outcome Measures

  1. Hair cortisol concentration [Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention]

    Hair cortisol concentration in the name of the outcome measure.

  2. Self-reported stress (extent of) [Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention]

    Cohen Stress Scale (Likert-type self-reported measurement) in the name of the outcome measure.

  3. Positive mood (extent of) [Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention]

    Positive And Negative Affect Scale International version (PANAS-I) (Likert-type self-reported measurement)

Other Outcome Measures

  1. Steps (number of) [Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention]

    total number of steps per day, assessed by Apple's Health Application on phones in the name of the outcome measure.

  2. Heart rate (average of beats per minute over days) [Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention]

    average beats per minute over days assessed by rate hear application on phones

  3. Sleep quality (extent of) [Baseline (pre-intervention), during intervention, immediate post-intervention, 3 months after intervention]

    14-item Sleep Questionnaire (Likert-type self-reported measurement)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion critieria:
  • 18 years or older

  • able to commit to a 9-month Nature Intervention (6-month walks; 3-month chosen nature activity)

  • spoken languages: English, Spanish, or Tagalog

  • able-bodied as in must be able to walk.

Exclusion criteria:
  • pregnant women (and other gender identities who are pregnant)

  • prisoners

  • cognitively impaired

Contacts and Locations

Locations

Site City State Country Postal Code
1 San Francisco State University San Francisco California United States 94132

Sponsors and Collaborators

  • Charlotte Tate
  • University of California, San Francisco

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Charlotte Tate, Full Professor, San Francisco State University
ClinicalTrials.gov Identifier:
NCT06056375
Other Study ID Numbers:
  • X21-013
First Posted:
Sep 28, 2023
Last Update Posted:
Sep 28, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2023